Mesenchymal stem cells with engineered HLA gene from induced pluripotent stem cells and a method for producing them
KR20190135946A
A patient-specific CCR5/CXCR4 gene knockout hematopoietic stem cells for treatment or prevention of HIV infection and method thereof
KR20190128961A
A method for producing directly reprogrammed induced neural stem cells from non-neuronal cells using Sox2 and c-Myc
KR20170110059A
Composition comprising GDF11 and uses thereof
CN109689075A
Compound and its application for being used to promote cartilage differentiation including no broken cartilage object and stem cell
WO2017123022A1
Stem cell-derived exosome containing high amount of growth factors
WO2017048097A1
Composition for preventing or treating inflammatory diseases, containing, as active ingredient, stem cells overexpressing sod3
KR101778953B1
Process for generating induced Neural Stem Cell using non-neural cell
KR20170093283A
Composition comprising GDF11 and uses thereof
WO2016048107A1
Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, comprising interferon-gamma or interleukin-1 beta treated stem cell or culture thereof
KR20160037099A
Pharmaceutical composition comprising stem cells treated with granules of mast cells or culture thereof for prevention and treatment of immune diseases and inflammatory diseases
KR20160031210A
Regulation method of proliferation, maintenance and differentiation of stromal cells by controlling hmga2 protein expression
